BioWorld

Sep. 12, 2005

View Archived Issues

Money Raised Year To Date

Stock Winners and Losers For The Week

Public Financing Of Biotechnology: August 2005

Other Financings Of Public Biotechnology Companies: August 2005

Venture Capital And Corporate Investments In Biotechnology Companies: August 2005

Money Raised By Month

Stock Indexes

BioWorld Stock Report For Public Biotechnology Companies

Novartis Tapping Alnylam; Sirna 'Sticks To Strategy'

"We think, unquestionably, we're the leaders," said Van Miles, senior vice president of business development for Alnylam Pharmaceuticals Inc., talking last week about RNA interference. Read More

Today's news in brief

BioWorld

BioWorld briefs for July 28, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for July 28, 2025.

Biocon wins first FDA interchangeable label of Novolog biosimilar

BioWorld Asia

The U.S. FDA on July 15 cleared Biocon Biologics Ltd.’s Kirsty (insulin aspart-xjhz) as the first and only interchangeable biosimilar product referencing Novo...

Illustration of Microglia cells (red) in Alzheimer´s disease

Two cancer drugs combined modify Alzheimer’s disease in mice

BioWorld

Current treatments for Alzheimer’s disease have limited effects. While they can slow cognitive decline or alleviate symptoms, they do not reverse this complex...

Proteomics finds surprise commonalities as well as differences in neurodegenerative diseases

BioWorld

The switch will be flicked today to make the world’s largest dementia-related proteomics dataset freely available to researchers, at the same time as members of...